Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Sadif Analytics Prime
$25.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Panion & BF Biotech Inc Announces Result of Phase Two Clinical Trial of Nephoxil


Tuesday, 5 Nov 2013 07:58pm EST 

Panion & BF Biotech Inc announced that its authorized partner Keryx has announced the positive result of the phase two clinical trial of Nephoxil (named as Zerenex in the United States), on the non-dialysis dependent chronic kidney disease. 

Company Quote

294.0
-4.11 -1.40%
24 Dec 2014